AI Key to Moderna's Successful Phase 3 Skin Cancer Vaccine
MxMnr · x · 2026-08-20
Moderna's personalized skin cancer vaccine has succeeded in a Phase 3 trial. Reports indicate that AI played a key role in designing the vaccine, demonstrating the significant potential of artificial intelligence in drug discovery and precision medicine.
More from Apps
- Benchling launches Science Foundries: agents and scientists running labs end-to-end — nlarusstone · 2026-10-16
- ChatGPT's Dot Reviewed: Your Chief of Staff Is Still Just a Codex Wrapper — infinitely_zero · 2026-10-16
- Perplexity API now available in Lovable apps for real-time cited web answers — AravSrinivas · 2026-10-16
- Nvidia NemoClaw makes TIME's Best Inventions of 2026 as an agent that can't break containment — NVIDIAAI · 2026-10-16
- Box AI Extract plus OpenAI Decisions API automates document routing — craigsdennis · 2026-10-16
- Full 49-minute walkthrough: editing Facebook ads with Opus 5.5 — alexgoughcooper · 2026-10-16